Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,551–6,575 of 7,816 matching trials · page 263 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Dual Task Training in Elderly Using the BioRescue NCT02681354 Biorescue training Runs in: Belgium · 2 sites |
NA other |
COMPLETED | 21 | Hasselt University OTHER |
2016-06-14 |
|
Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention NCT01802554 Pleasant Events Program (PEP); Information Support (IS) Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | University of California, San Diego OTHER |
2016-06-13 |
|
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients NCT00676143 bapineuzumab; placebo Runs in: Argentina; Australia; Austria; Belgium; Chile; Croatia; F... · 288 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 1,100 | Pfizer INDUSTRY |
2016-06-10 |
|
Determinants of Quality of Life Related to Health in Alzheimer Disease NCT01570322 Runs in: France · 1 site |
NA other |
UNKNOWN | 400 | CHU de Reims OTHER |
2016-06-09 |
|
Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment NCT02778581 Lipidic Blend 1; Lipidic Blend 2; Placebo Runs in: Spain · 2 sites |
NA other |
UNKNOWN | 110 | Team Foods Colombia S.A. INDUSTRY |
2016-06-03 |
|
[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET. NCT02061722 PET Imaging with [18F]MNI-659 Runs in: Denmark; Netherlands; Norway; Sweden · 8 sites |
EARLY_PHASE1 other |
COMPLETED | 90 | CHDI Foundation, Inc. OTHER |
2016-06-01 |
|
A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia NCT01055561 Acupuncture Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 30 | Chengdu University of Traditional Chinese Medicine OTHER |
2016-05-30 |
|
Bioavailability of Ubiquinol in Huntington Disease NCT00980694 ubiquinol Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 6 | University of Rochester OTHER |
2016-05-27 |
|
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology NCT01020838 Florbetaben (BAY94-9172) Runs in: Australia; France; Germany; Japan; United States · 19 sites |
PHASE3 other |
COMPLETED | 218 | Lantheus Biosciences Ltd. INDUSTRY |
2016-05-27 |
|
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline NCT01746303 Omega-3 fatty acid; Blueberry powder; Placebo oil; Placebo powder Runs in: United States · 1 site |
NA other |
COMPLETED | 94 | University of Cincinnati OTHER |
2016-05-27 |
|
The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery NCT02782429 Ketamine; Saline Runs in: Brazil · 1 site |
PHASE4 other |
UNKNOWN | 50 | Flavia orange OTHER |
2016-05-25 |
|
Treatment of Behavioral Symptoms in Alzheimer's Disease NCT00009217 Haloperidol-Haloperidol; Haloperidol-Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 44 | New York State Psychiatric Institute OTHER |
2016-05-24 |
|
Oculomotor Testing in the Differential Diagnosis of Dementia NCT01577394 oculomotor measurements Runs in: France · 1 site |
PHASE3 other |
COMPLETED | 65 | Assistance Publique - Hôpitaux de Paris OTHER |
2016-05-23 |
|
Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters NCT00291161 Partners in Dementia Care Runs in: United States · 6 sites |
NA other |
COMPLETED | 994 | VA Office of Research and Development OTHER_GOV |
2016-05-19 |
|
MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) NCT00362024 MK0952; Comparator: Placebo |
PHASE2 other |
TERMINATED | 24 | Merck Sharp & Dohme LLC INDUSTRY |
2016-05-16 |
|
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets NCT01400113 Asenapine; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 120 | Unity Health Toronto OTHER |
2016-05-16 |
|
Treatment of Trauma and Violence in the Townships of South Africa NCT02012738 FORNET; CBT; Waiting List Control Group (camp); Waiting List Contro... Runs in: South Africa · 1 site |
NA other |
COMPLETED | 45 | University of Konstanz OTHER |
2016-05-13 |
|
Neurostimulation and Cognitive Intervention in Alzheimer's Disease NCT02772185 active tDCS; sham tDCS; real CT; placebo CT Runs in: Brazil · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 60 | Federal University of Paraíba OTHER |
2016-05-13 |
|
Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease NCT01716637 Etanercept; Curcum.Luteol.Theaflav.Lip.Acid,FishOil,Quercet.,Resveratr. Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 12 | Life Extension Foundation Inc. OTHER |
2016-05-12 |
|
Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men NCT02010476 Runs in: Finland · 1 site |
NA other |
COMPLETED | 58 | University of Eastern Finland OTHER |
2016-05-12 |
|
A Study of a Memory Intervention to Improve MA in PWMCI & FCG MA NCT02761655 Memory Strategies Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 200 | Chang Gung University OTHER |
2016-05-10 |
|
A Randomised Controlled Trial of Home-based Exercise Intervention for Caregivers of Persons With Dementia NCT02132039 12-step sitting Tai Chi Chuan; Control Runs in: China · 5 sites |
NA other |
UNKNOWN | 272 | The University of Hong Kong OTHER |
2016-05-06 |
|
Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease NCT02222181 Pharmacotherapy Management Runs in: Brazil · 1 site |
NA other |
COMPLETED | 55 | Universidade Estadual Paulista Júlio de Mesquita Filho OTHER |
2016-05-06 |
|
Violence Prevention for Adolescent Girls With Prior Maltreatment NCT02765048 GAIN Program Runs in: United States · 3 sites |
NA other |
COMPLETED | 312 | Washington University School of Medicine OTHER |
2016-05-06 |
|
Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients NCT01312363 Rivastigmine patch Runs in: South Korea · 19 sites |
NA symptomatic-cholinergic |
COMPLETED | 300 | Seoul National University Hospital OTHER |
2016-05-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial